NO920983L - Fremgangsmaate for behandling av nevrodegenerative tilstander - Google Patents

Fremgangsmaate for behandling av nevrodegenerative tilstander

Info

Publication number
NO920983L
NO920983L NO92920983A NO920983A NO920983L NO 920983 L NO920983 L NO 920983L NO 92920983 A NO92920983 A NO 92920983A NO 920983 A NO920983 A NO 920983A NO 920983 L NO920983 L NO 920983L
Authority
NO
Norway
Prior art keywords
nevrodegenerative
procedure
treatment
conditions
nevrodegenerative conditions
Prior art date
Application number
NO92920983A
Other languages
English (en)
Other versions
NO920983D0 (no
Inventor
Paul Jerome Marangos
Harry Edward Gruber
Original Assignee
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Pharma filed Critical Gensia Pharma
Publication of NO920983L publication Critical patent/NO920983L/no
Publication of NO920983D0 publication Critical patent/NO920983D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Treatment Of Fiber Materials (AREA)
  • Saccharide Compounds (AREA)
NO1992920983A 1989-09-15 1992-03-13 Fremgangsmaate for behandling av nevrodegenerative tilstander NO920983D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40791389A 1989-09-15 1989-09-15
PCT/US1990/005180 WO1991004032A1 (en) 1989-09-15 1990-09-12 Methods of treating neurodegenerative conditions

Publications (2)

Publication Number Publication Date
NO920983L true NO920983L (no) 1992-03-13
NO920983D0 NO920983D0 (no) 1992-03-13

Family

ID=23614067

Family Applications (1)

Application Number Title Priority Date Filing Date
NO1992920983A NO920983D0 (no) 1989-09-15 1992-03-13 Fremgangsmaate for behandling av nevrodegenerative tilstander

Country Status (6)

Country Link
EP (1) EP0491792A4 (no)
JP (1) JPH05506842A (no)
KR (1) KR920703068A (no)
AU (1) AU643235B2 (no)
NO (1) NO920983D0 (no)
WO (1) WO1991004032A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233330T2 (de) * 1991-08-09 2005-03-10 Massachusetts Institute Of Technology, Cambridge Verwendung eines inhibitors der tau/neurofilament proteinkinase pk40
DK62592D0 (no) * 1992-05-14 1992-05-14 Novo Nordisk As
EP0582164B1 (en) * 1992-07-31 1998-12-23 Bristol-Myers Squibb Company Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
US5780450A (en) * 1995-11-21 1998-07-14 Alcon Laboratories, Inc. Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US6440455B1 (en) * 1997-09-02 2002-08-27 Children's Medical Center Corporation Methods for modulating the axonal outgrowth of central nervous system neurons

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells

Also Published As

Publication number Publication date
AU643235B2 (en) 1993-11-11
KR920703068A (ko) 1992-12-17
EP0491792A1 (en) 1992-07-01
NO920983D0 (no) 1992-03-13
WO1991004032A1 (en) 1991-04-04
JPH05506842A (ja) 1993-10-07
EP0491792A4 (en) 1992-12-02
AU6401590A (en) 1991-04-18

Similar Documents

Publication Publication Date Title
NO934304L (no) Fremgangsmaate for behandling av fluoralumosilikatglass
NO173498C (no) Analogifremgangsmaate for fremstilling av substituerte 9-amino-tetrahydroakridiner
NO902003D0 (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO901554D0 (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO921962D0 (no) Fremgangsmaate til fremstilling av kokevaesker for sulfatmassekoking
NO171974C (no) Fremgangsmaate for fremstilling av nafthalenderivater
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
NO921993D0 (no) Fremgangsmaate for efterbehandling av amfotaere eller zwitterioniske tensider
NO920983D0 (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO893890L (no) Fremgangsmaate for fjerning av sulfider.
NO901067L (no) Fremgangsmaate for fremstilling av tiofener.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO171373C (no) Fremgangsmaate for fremstilling av biskarbamater
FI902590A7 (fi) Menetelmä 2-oksoindoli-1-karboksamidien valmistamiseksi
NO901422L (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
NO884635D0 (no) Fremgangsmaate for behandling av most.
KR890701106A (ko) 과지혈증의 치료를 위한 옥소퀴나졸린 유도체의 용도
NO920694D0 (no) Fremgangsmaate for etterbehandling av tremasse
NO171565C (no) Fremgangsmaate for behandling av manganslam
NO904070D0 (no) Fremgangsmaate for fremstilling av alkanfenoner.
NO902968D0 (no) Fremgangsmaate for behandling av boreslam.
NO930481L (no) Fremgangsmaate for fremstilling av klormetaner
FI904950A7 (fi) Menetelmä 3-alkoksi-4-hydroksibentsaldehydien valmistamiseksi
NO914468D0 (no) Anvendelse av melatoninderivater for prevensjon